The TRP degradation pathway plays an influential role in cancer biology via indoleamine 2,3-dioxygenase (IDO), where KYN acts as a ligand for an aryl hydrocarbon receptor (AhR) to promote tumor progression and metastasis (Opitz et al., 2011). The gene discussed is IDO1; the disease is neoplasm.